FDA To Expand Postmarket Surveillance Of Medical Devices, Per GAO Report Requested By Lawmakers

A government report requested by US lawmakers Debbie Dingell and Anna Eshoo to review the FDA’s postmarket surveillance of medical devices stresses that strengthening the system is critical to addressing adverse events linked to devices after they hit the market.